The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over 2 seasons.

RSV, or respiratory syncytial virus, is a common illness that can cause serious breathing problems in infants, young children ...

A large, real-world randomized trial in Denmark found that the RSVpreF vaccine reduced RSV-related hospitalizations in adults ...

Mandy Moore recalls when her sons were both diagnosed with RSV in 2023, and how the scary health ordeal made her feel in an ...

Comorbidities are seen less often in severe RSV infection in infants younger than 3 months compared with older children.

Manitoba is expanding its immunization program to help protect infants who are born during respiratory syncytial virus season ...

In Florida, many pharmacists, doctors, and patients find themselves confused about who has access to vaccines for COVID-19, ...

Nova Scotia is spending $6.9 million to launch a new program to vaccinate or protect infants and some seniors against ...

One shot of an RSV vaccine protects adults ages 60 or older from RSV-associated hospitalization and critical illness during ...

“Over the age of 60, your immune system becomes a little less active,” he explains, meaning it can be harder to fend off ...

GSK announced today that Arexvy (respiratory syncytial virus vaccine – recombinant, AS01E adjuvanted) will be offered through ...

HealthDay News — The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published in JAMA Network Open.